spacer
home > ebr > summer 2008 > dealing with the deluge
PUBLICATIONS
European Biopharmaceutical Review

Dealing with the Deluge

Flow cytometry is a technique for cell characterisation that is popularly used in basic and translational research for understanding, for example, how mutated stem cells may confer therapy resistance to a tumour (1). Alternatively, cell characterisation can be used to measure cell receptors during activation or as a response to immunosuppressive drugs. A flow cytometer consists of a narrow, hydrodynamically-focused stream of cells that pass and are interrogated by a light source. The cells’ physical characteristics of size and granularity, as well as any fluorescent labels attached in or on the cells, scatter the beam of light. Fluorescent labels attached will then be excited, enabling the appropriate emission characteristics to be measured in relative terms of fluorescent intensity.

Flow cytometer manufacturers have responded to the needs of modern researchers by developing faster systems that can measure more variables over shorter time periods for applications such as detecting tumour cells in peripheral blood and examining different aspects of stem cell differentiation. However, the ability of the software that flow cytometers rely on to analyse and visualise the rapidly rising tide of data now being generated has lagged way behind these improvements in instrument technology. This article examines some of the approaches that enlightened software manufacturers are now taking to speed up and simplify data analysis and support the revolution in flow cytometry research.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Gillian Byrne is the Product Specialist of Applied Cytometry. Gillian’s responsibilities include establishing and maintaining expert technical knowledge of the company’s products and determining the market needs for effective product launch strategies. She plays an active role in developing business relationships with customers of the flow cytometry industry as well as displaying her expert product knowledge at global industry related events. As a biomedical science graduate, Gillian’s career was mainly spent in the public sector before venturing into the private sector, working as a state registered biomedical scientist for a clinical microbiology laboratory. Here she gained valuable skills in all aspects of bacteriology, serology and molecular biology, giving her first hand experience of the biomedical industry.
spacer
Gillian Byrne
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Quanterix Launches the First Comprehensive Multiplex Panel to Study Traumatic Brain Injury Severity


More info >>

White Papers

The Impact of Components on Drug Quality and Risk Mitigation

West Pharmaceutical Services, Inc.

Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety. The trend has resulted in delays for new drug applications, more recalls of marketed products and even drug shortages if the container system and drug contents are suspect for quality issues. The pharmaceutical market is now requiring manufacturers of containers and components to meet new expectations with a quality culture and very high product reliability. The need to bridge the gap and provide superior quality products has been a driver for manufacturing technology investments, more robust control strategies and the introduction of next generation elastomer components.
More info >>

 
Industry Events

BioPharm America™ 2017—10th Annual International Partnering Conference

26-27 September 2017, 39 Dalton Street, Boston, MA 02116

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement